Unknown

Dataset Information

0

A Heparin Binding Motif Rich in Arginine and Lysine is the Functional Domain of YKL-40.


ABSTRACT: The heparin-binding glycoprotein YKL-40 (CHI3L1) is intimately associated with microvascularization in multiple human diseases including cancer and inflammation. However, the heparin-binding domain(s) pertinent to the angiogenic activity have yet been identified. YKL-40 harbors a consensus heparin-binding motif that consists of positively charged arginine (R) and lysine (K) (RRDK; residues 144-147); but they don't bind to heparin. Intriguingly, we identified a separate KR-rich domain (residues 334-345) that does display strong heparin binding affinity. A short synthetic peptide spanning this KR-rich domain successfully competed with YKL-40 and blocked its ability to bind heparin. Three individual point mutations, where alanine (A) substituted for K or R (K337A, K342A, R344A), led to remarkable decreases in heparin-binding ability and angiogenic activity. In addition, a neutralizing anti-YKL-40 antibody that targets these residues and prevents heparin binding impeded angiogenesis in vitro. MDA-MB-231 breast cancer cells engineered to express ectopic K337A, K342A or R344A mutants displayed reduced tumor development and compromised tumor vessel formation in mice relative to control cells expressing wild-type YKL-40. These data reveal that the KR-rich heparin-binding motif is the functional heparin-binding domain of YKL-40. Our findings shed light on novel molecular mechanisms underlying endothelial cell angiogenesis promoted by YKL-40 in a variety of diseases.

SUBMITTER: Ngernyuang N 

PROVIDER: S-EPMC5773473 | biostudies-literature | 2018 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

A Heparin Binding Motif Rich in Arginine and Lysine is the Functional Domain of YKL-40.

Ngernyuang Nipaporn N   Yan Wei W   Schwartz Lawrence M LM   Oh Dennis D   Liu Ying-Bin YB   Chen Hongzhuan H   Shao Rong R  

Neoplasia (New York, N.Y.) 20171220 2


The heparin-binding glycoprotein YKL-40 (CHI3L1) is intimately associated with microvascularization in multiple human diseases including cancer and inflammation. However, the heparin-binding domain(s) pertinent to the angiogenic activity have yet been identified. YKL-40 harbors a consensus heparin-binding motif that consists of positively charged arginine (R) and lysine (K) (RRDK; residues 144-147); but they don't bind to heparin. Intriguingly, we identified a separate KR-rich domain (residues 3  ...[more]

Similar Datasets

| S-EPMC1440312 | biostudies-literature
| S-EPMC2980704 | biostudies-literature
| S-EPMC5021326 | biostudies-literature
| S-EPMC3752131 | biostudies-literature
| S-EPMC4621093 | biostudies-literature
| S-EPMC6351153 | biostudies-literature
| S-EPMC7180208 | biostudies-literature
| S-EPMC4615805 | biostudies-literature
| S-EPMC2966416 | biostudies-literature
| S-EPMC8521312 | biostudies-literature